✦ LIBER ✦

Circadian tolerance to etoposide and cisplatin as first line treatment for advanced lung carcinoma

Book ID: 122866863
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 161 KB
Volume: 7
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(91)90365-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of first-line chemotherap

Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma

✍ Urakami, Shinji; Fujii, Yasuhisa; Yamamoto, Shinya; Yuasa, Takeshi; Kitsukawa, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 195 KB

A multicenter, randomized, Phase II stud

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun

6623 Cisplatin plus etoposide as first-l

6623 Cisplatin plus etoposide as first-line chemotherapy for poorly- differentiated neuroendocrine carcinoma of the hepatobiliary and pancreatic region

✍ Iwasa, S.; Morizane, C.; Okusaka, T.; Ueno, H.; Ikeda, M.; Kondo, S.; Kojima, Y. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Weekly low dose paclitaxel and cisplatin

Weekly low dose paclitaxel and cisplatin as first-line chemotherapy for advanced non-small cell lung cancer

✍ Kim, Sang-We; Suh, Cheolwon; Lee, Sang Do; Kim, Woo Sung; Kim, Dong Soon; Kim, W 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 203 KB

A randomized study of chemotherapy with

A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state

✍ P. Lissoni; F. Paolorossi; A. Ardizzoia; S. Barni; M. Chilelli; M. Mancuso; G. T 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Cisplatin plus vinorelbine as first-line

Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?

✍ Provencio, Mariano; de Las Peñas, Ramón; Camps, Carlos; Artal, Angel; Massuti, B 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB